bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Andrew Obenshain$187.1M
Market Cap • 23/04/20241992
(há 32 anos)
2013
(11 years ago)
NASDAQ
Listagem
Somerville
Sede • Massachusetts323
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
BLUESó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.